Skip to main content

Table 1 Baseline demographic characteristics of MS participants in the CBT and TAU groups

From: A pilot randomized controlled trial of a tailored cognitive behavioural therapy based intervention for depressive symptoms in those newly diagnosed with multiple sclerosis

  CBT intervention
(n = 15)
TAU
(n = 15)
Age (M, SD) 34.60 (9.06) 39.27 (9.93)
Time since diagnosis in months (M, SD) 26.20 (15.58) 23.53 (16.06)
Months since first MS symptoms (M, SD) 35.54 (16.47) 30.57 (18.68)
Gender (n)% female (13) 86.7% (9) 60%
Years of education (n)%
 Secondary (4) 26.7% (3) 20%
 Trade, Tafe or Diploma (4) 26.7% (4) 26.7%
 Undergraduate (3) 20% (2) 13.3%
 Postgraduate (4) 26.7% (6) 40%
Employment status (n)%
 Unemployed (4) 27% (5) 33.3%
 Part time (4) 27% (4) 27%
 Full time (7) 47% (6) 40%
Marital status (n)%
 Single (2) 13% (0) 0%
 Partnered/Married (13) 86.6% (15) 100%
Ethnic background (n)%
 Australian (11) 73% (10) 66.6%
 Other (4) 26.6% (5) 33.3%
Ambulation status (n)%
 Able to walk independently without aid (15) 100% (15) 100%
MS type (n) %
 Relapse remitting (15) 100% (15) 100%
Currently taking MS disease modifying medication
 Yes (n)% (12) 80% (10) 66.7%
Currently taking antidepressant medication
 Yes (n)% (6) 40% (5) 33.3%
 How long on this medication in months (M, SD) 24.33 (20.68) 25.20 (15.53)
Previously diagnosed with depression
 Yes (n)% (8) 53.3% (7) 46.7%
Previously diagnosed with anxiety
 Yes (n)% (6) 40% (6) 40%
  1. M Mean, SD standard deviation, TAU Treatment as usual control group